Emerging Paradigms in Delivery Systems for Antitubercular Therapy

Dr. Sharma earned his B. Pharm, M. Pharm and Ph.D. form Pharmaceutical Sciences, Dr. H. S. Gour Central University, Sagar, India. As Assistant Professor, he served in academia at Guru Ramdas Khalsa institute of Science and Technology Jabalpur (M.P.). He has the past experience as Junior research fellow-AICTE, ICMR-SRF and CSIR- research associate during his academic career and currently, working as an assistant manager in biologicals research and development division. He has edited 1 international book Nano Drug Delivery Strategies for the Treatment of Cancers and he published dozens of publications and book chapters. His current research interests are nanocarriers based targeted approach for the effective delivery of bioactives. Dr. Neeraj Mishra is a Professor and Head of the Department of Pharmaceutics at Amity Institute of Pharmacy, India, a position he has held since July 2019. With nearly two decades of teaching and research experience, Dr. Mishra has authored over 100 publications on novel drug delivery systems, focusing on nanocarriers and microparticles for treating breast and colon cancer, as well as neurodegenerative disorders. He has written several books and book chapters, and holds three international and two Indian patents. Dr. Mishra has received numerous accolades, including the "Distinguished Professor Award" (2019, 2021) and the "Outstanding Scientist Award" (2020). He has served as a guest editor for Bentham Sciences and is recognized in Stanford University's World Scientists Rankings for 2022 and 2024. Laxmikant Gautam is a PhD Scholar in the Department of Pharmaceutical Sciences, Dr. Harisingh Gour University, Sagar, Madhya Pradesh, India. Professor S.P. Vyas works in the Department of Pharmacy, Dr. Harisingh Gour University, Sagar, Madhya Pradesh, India.

1. Introduction: An Overview of Novel Approaches for the Treatment of Tuberculosis
2. Theragnostic Approaches for the Management of Tuberculosis
3. Role of Inorganic Nanoparticles for the Treatment of Tuberculosis
4. Role of Polymeric Nanoparticles for the Treatment of Tuberculosis
5. Role of Vesicular Carriers for the Treatment of Tuberculosis
6. Polymeric Micelles in Therapy of Tuberculosis
7. Herbal Approaches for the Treatment of Tuberculosis
8. Role of Gut-lung axis in Tuberculosis
9. Mucoadhesive Drug Delivery System(s) for the Treatment of Tuberculosis
10. Current Gene Therapy Approaches for the Treatment of Tuberculosis
11. Novel Targets and Drugs for the Treatment of Tuberculosis
12. Targeting Inflammation and Oxidative Stress for the Treatment of Tuberculosis
13. Potential Approaches for the Treatment of Drug-resistant Tuberculosis
14. Targeted Drug Delivery to the Macrophagic Cellular Tropics in Tuberculosis
15. Combination Antitubercular Therapy Using Nanomedicine to Treat and Eradicate Tuberculosis
16. Tuberculosis Vaccines: Advancements and Ongoing Clinical Trials
17. Future Prospects and Regulatory Aspects for the Management of Tuberculosis